Article - Billing and Coding: MolDx: BCR-ABL (A55233) CPT codes 81206, 81207, and 81208 may only be reported when performed as a single test To submit a claim for BCR-ABL translocation analysis by NGS, use CPT 81479 and one (1) UOS with the assigned DEX Z-code
Presentation - Quest Diagnostics CPT Codes 81206, 81207, and 81208 BCR ABL is considered medically necessary in the evaluation of individuals with chronic myelogenous leukemia or BCR-ABL positive acute lymphoblastic leukemia to evaluate treated individuals who manifest suboptimal response to initial tyrosine kinase inhibitor therapy or loss of response to tyrosine kinase
Procedure Codes 81206 and 81207 Open for Billing Effective November 1, 2024, procedure codes 81206 (BCR ABL1 Gene Major BP) and 81207 (BCR ABL1 Gene Minor BP) may be billed by provider type 43 (Laboratory, Pathology Clinical)
CPT® Code 81207 in section: BCR ABL1 (t (9;22)) 81207 - CPT® Code in category: BCR ABL1 (t (9;22)) CPT Code information is available to subscribers and includes the CPT code number, short description, long description, guidelines and more CPT code information is copyright by the AMA
Medicare Local Coverage Determination Policy This policy provides coverage for multi-gene non-next generation sequencing (NGS) panel testing and NGS testing for the diagnostic workup for myeloproliferative disease (MPD), also known as myeloproliferative neoplasms (MPNs), and limited coverage for single-gene testing of patients with BCR-ABL negative MPD
81207 CPT4 - GenHealth. ai This test analyzes the genetic material in your blood or bone marrow to detect and measure the BCR ABL1 gene fusion This gene fusion, also known as the Philadelphia chromosome, is commonly associated with chronic myelogenous leukemia (CML) and other types of leukemia